trending Market Intelligence /marketintelligence/en/news-insights/trending/joqniktoxdovvpapeoj_ea2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *

* Required

In this list

Mylan launches generic version of seizure injections

Liberty Global: The Great Global Sell-Off

Street Talk Episode 52 - A bank's 'knife fight' to stay high performing in a low rate environment

Streaming Media Devices Feel The Squeeze In Q3'19

AT&T To Use Wireless Subs To Create Buzz For HBO


Mylan launches generic version of seizure injections

Mylan NV launched a generic version of Pfizer Inc.'s Cerebyx injection in the U.S.

The fosphenytoin sodium injections will be available in single-use vials for the treatment of certain types of seizures.

The treatment had U.S. sales of approximately $36.3 million for the 12 months ending Oct. 31, according to IMS Health.